⬆
✘
 
By continuing to use the site, you allow the use of Cookies and agree to the privacy policy.
.,о.,р..и.:г,.и.,н.;н.,а;,л.. .,н.:а,.х.,о.,д.;и.,т..с.:я,, ..н.;а., .,k;,i..b.:e,;r.,i.,s.,.;.r.:u,
⌂ /Homeopathy /
 Share

Carcinosinum burnett

Sources : Kiberis
EN: Boericke, Clarke, Phatak
RU: Additions, Берике, Вермюлен, Витулкас2, Кларк, Кулкарни, Моррисон, Фатак, Фундылер
Sound forms: ✘Вы не авторизованы . Is required PRO account or access to audio drugs ✘Вы не авторизованы . Is required PRO account or access to audio drugs ✘Вы не авторизованы . Is required PRO account or access to audio drugs
ⓘ Learn more about digital audio preparations

Other names and synonyms

carc.

Performance statistics based

X
 
  • ↑
    ↑
    ↑
  • 2
    Back: E 51%, I 20%, 9 cases. 874 meds
    • 1
      Nervous system: E 41%, I 16%, 15 cases. 600 meds
      • 10
        Head: E 37%, I 15%, 67 cases. 1231 meds
        • 5
          Genitourinary system: E 46%, I 13%, 25 cases. 684 meds
          • 4
            Bone system: E 36%, I 11%, 22 cases. 278 meds
            • 11
              Psyche: E 31%, I 10%, 80 cases. 1271 meds
              • 7
                Limbs: E 32%, I 8%, 41 case. 928 meds
                • 3
                  Chest: E 38%, I 7%, 13 cases. 1020 meds
                  • 12
                    Skin: E 33%, I 7%, 56 cases. 1256 meds
                    • 9
                      Digestive system: E 36%, I 6%, 57 cases. 1273 meds
                      • 5
                        Respiratory system: E 45%, I 5%, 33 cases. 1007 meds
                        • 3
                          Abdomen: E 63%, I 4%, 15 cases. 1065 meds
                          • 19
                            Diseases: E 39%, I 4%, 55 cases. 1881 meds
                            • 2
                              Anamnesis: E 26%, I 2%, 36 cases. 698 meds
                              • 3
                                Cardiovascular system: E 38%, I 1%, 16 cases. 1118 meds
                                • 2
                                  The muscular system: E 41%, I -3%, 7 cases. 246 meds
                                  • 1
                                    Pelvis: E 43%, I -8%, 4 cases. 476 meds
                                    • 1
                                      Neck: E 20%, I -18%, 16 cases. 719 meds

                                      Last updated date: 14.07.2026

                                      Performance statistics based «Carcinosinum burnett» in percentages for various lesions, grouped by meaning in the form of a repertory. Together with individual modalities that affect the outcome of therapy.
                                      Effect - how much the symptom improves in one treatment cycle on average. Example: drug Pain relief for cancer pain-Effectiveness (E) is high, but the effect (I) negative, because the patient will get worse over time.
                                      Influence of the symptom on the outcome of the patient's treatment as a whole (i.e., the importance of the symptom). Example: menopause can not be cured (E low). But some means during menopause will be better than others (I high).
                                      Cases - the number of investigated treatment results for a given complaint, on the basis of which the effect and effect were calculated. These cases have already passed automatic AI verification of data quality and reliability.
                                      ✘Available only when using PRO account
                                      Content moderator: Vasin A. S.


                                      1. Kiberis is NOT an online store and does NOT purchase, store, sell or deliver drugs. The resource acts only as an intermediary between you and the manufacturer of drugs or pharmacy points, which carry out the delivery.
                                      2. On Kiberis there are descriptions of drugs, some of which are intended only for doctors. This information cannot be used by patients to make decisions about the use of drugs, their cancellation or correction of dosages.
                                      3. Nothing in the information provided should be interpreted as a call to use these drugs.
                                      4. No claims can be made to Kiberis regarding any damage or harm incurred as a result of the use of the information posted on the site.